SEC Comment Letter 0000000000-24-012753 to Milestone Pharmaceuticals Inc. (MIST) (CIK 0001408443) (MIST)
Milestone Pharmaceuticals Inc. (MIST) (CIK 0001408443)
Date: Nov. 19, 2024 · CIK: 0001408443 · Accession: 0000000000-24-012753
AI Filing Summary & Sentiment
File numbers found in text: 333-283162
Letter
November 19, 2024 Joseph Oliveto Chief Executive Officer Milestone Pharmaceuticals Inc. 7422 Carmel Executive Park Drive, Suite 300 Charlotte, NC 28226 Re:Milestone Pharmaceuticals Inc. Registration Statement on Form S-3 Filed November 12, 2024 File No. 333-283162 Dear Joseph Oliveto: This is to advise you that we have not reviewed and will not review your registration statement. Please refer to Rules 460 and 461 regarding requests for acceleration. We remind you that the company and its management are responsible for the accuracy and adequacy of their disclosures, notwithstanding any review, comments, action or absence of action by the staff. Please contact Chris Edwards at 202-551-6761 with any questions. Sincerely, Division of Corporation Finance Office of Life Sciences cc:Ryan Sansom
Show Raw Text
November 19, 2024
Joseph Oliveto
Chief Executive Officer
Milestone Pharmaceuticals Inc.
7422 Carmel Executive Park Drive, Suite 300
Charlotte, NC 28226
Re:Milestone Pharmaceuticals Inc.
Registration Statement on Form S-3
Filed November 12, 2024
File No. 333-283162
Dear Joseph Oliveto:
This is to advise you that we have not reviewed and will not review your registration
statement.
Please refer to Rules 460 and 461 regarding requests for acceleration. We remind you
that the company and its management are responsible for the accuracy and adequacy of their
disclosures, notwithstanding any review, comments, action or absence of action by the staff.
Please contact Chris Edwards at 202-551-6761 with any questions.
Sincerely,
Division of Corporation Finance
Office of Life Sciences
cc:Ryan Sansom